News | August 02, 2023
Bliss GVS Pharma Q1 FY2024 consolidated PAT up at Rs. 14.68 Cr
The company has reported total income of Rs. 164.63 crores during the period ended June 30, 2023
The company has reported total income of Rs. 164.63 crores during the period ended June 30, 2023
JDHL has a strong reputation as an end-to-end design-focused manufacturer of electro-medical devices
The company achieved 100% capacity utilisation in the division. These accomplishments stand as a testament to the company's dedication and vision
The company has secured 506 marketing approvals for its oncology products across 76 countries.
Jemperli is the only immuno-oncology treatment approved in the frontline setting for this patient population in combination with chemotherapy
Proposed acquisition represents meaningful step forward in Biogen’s strategy for sustainable growth
Unfortunate to see PM’s ‘Make in India’ dream being bulldozed
The approved product has an estimated market size of around US$ 210 million for the twelve months ending May 2023
Teva will leverage Honeywell’s ‘Energy as a Service’ (EaaS) model
Through the use of robotic assisted orthopaedic surgeries, the success rate is close to 98%
Subscribe To Our Newsletter & Stay Updated
